Product
Topical treatment for psoriasis and vitiligo.

Studies
Photocil safely and effectively permits phototherapy treatments at home by blocking harmful radiation and permitting the passage of therapeutic UV radiation.

Sales Channels
Photocil became commercially available in the United States in Q4 2022 as an FDA-approved OTC product under a USP monograph for psoriasis and vitiligo.

Next Steps
The scientific formulation is finished, and clinical research is currently in progress.